NCT Number: NCT03803839
Locally Administered Clodronate in the Prevention of Aseptic Implant Loosening
Periprosthetic bone-loss after total hip arthroplasty (THA), detected as an early migration of the prosthesis, may predict later loosening. The investigators hypothesized that by reducing bone resorption after THA with bisphosphonates, it might be possible to achieve better early fixation of the implant.
Nineteen patients suffering arthrosis were recruited to a prospective, double-blinded, randomized, placebo-controlled clinical pilot trial. Patients were operated with an uncemented Bimetric stem with tantalum markers, the acetabular cup and liner were chosen by the surgeon. The femoral proximal intramedullary canal was rinsed with 1mM (millimole) clodronate, that was done by adding the clodronate to the 1000 ml 0.9% NaCl (sodium chloride) in nine patients and rinsing solution was the pure 0.9% NaCl for 10 patients. These rinsing packages were labeled only with the code from the pharmacy of the hospital. These patients were followed for two years using radiostereometric analysis (RSA), dual energy x-ray absorptiometry (DXA) and the Harris hip score (HHS).
The purpose of the investigator's study was to examine whether the local intraoperative administration of clodronate could reduce periprosthetic bone loss and further stem migration after primary THA.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 73 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Early Phase 1
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- hip arthrosis and
- a primary THA was planned
Exclusion criteria
- renal insufficiency
- hypercalcemia
- malignant tumors
- contemporaneously treatment with another bisphosphonate or aminoglycoside
Treatment and study plan
Saline
DrugPrimary outcomes
-
Maximal total point motion (MTPM) - migration of the femoral stem
Time frame: 0 to 24 months
It represents the length of the translation vector of the point in a rigid body that has the greatest motion. It can only have positive values, and is not normally distributed. The reason for using MTPM is that in many cases, motion implies a biological effect of some kind and this effect is liable to be greatest at the point of maximum motion. The parameter has been measured by RSA-methods, which is an accurate method of determining the migration and wear of orthopaedic implants: it determine the precise location of two distinct objects relative to each other in three dimension such as the relative position of the femoral component and the proximal femur. In radiostereometric analysis the position in space of the original object is reconstructed from a two dimensional x-ray film using tantalum beads. Movement between segments is then calculated by localizing each segment in a coordinate system. Lower values represent a better outcome.
Secondary outcomes
-
Bone mineral density (BMD) in 7 Gruen zones
Time frame: 0 to 24 months
BMD was measured by dual-energy X-ray absorptiometry, DXA. In clinical use, precision errors are < 5 %. To evaluate the horizontal linear distribution of the BMD, seven Gruen zones, peri-prosthetic sub-regions of interest, ROI (region of interest) were calculated by the software on the anteroposterior view of the proximal femur. The value of BMD is g/cm2 and it estimates the strength of the bone. Higher values/lesser decrease in values represent a better outcome.
Other outcomes
-
Migration of femoral stem
Time frame: 0 to 24 months
Subsidence and vertical movement of the femoral stem (scale micrometers), x-, y- and z-translations. Parameters were measured using RSA-methods and the scaling is linear. Lower values represent a better outcome.
-
The maximal (MTPM) maximal total point motion
Time frame: 3 to 24 months
The maximal MTPM value after 3 months when the expected integration of stem should have happened. Lower values represent a better outcome.
-
Correlation between baseline BMD and the maximal MTPM
Time frame: BMD (0 month) - the maximal MTPM 3 to 24 months
This parameters summarize the BMD and RSA values together. The investigators have planned it to evaluate the correlation between the quality of periprosthetic bone in baseline and the migration of femoral stem during 2 years follow-up period between the study groups.
-
Harris Hip Score (HHS)
Time frame: 0 to 24 months
Harris Hip Score (HHS) is a clinician-based outcome measure, health status scale, that is frequently used to measure the outcome of total hip arthroplasty. It is measured by questionnaire that give points from 0 to 100. Higher values represent a better outcome.
Sponsors and collaborators
Lead sponsor
University of Oulu
Other
Registry information
Official study title
Could the Intra-operative Clodronate Rinsing Improve the Integration of the Femoral Stem in a Prospective, Double-blinded, Randomized, Placebo-controlled Clinical RSA-study
Important dates
- Study start
- 2004
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Jan 15, 2019
- Registry last updated
- Jan 18, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Interprofessional Preoperative Geriatric Assessment for Older Arthroplasty Patients With Multimorbidity
NCT04001699
Arthritis, Hip Arthrosis
Kuopio, Finland
View Trial DetailsSuperiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery
NCT06257160
Agnosia, Arthritis
Reims, France
View Trial DetailsPatient Reported Outcome Measures (PROMs) in Rehabilitation With or Without the Possible Use of a Mobile Application After Primary Knee or Hip Arthroplasty
NCT04628468
Arthritis, Arthroplasty, Replacement, Knee
Antwerp, Belgium
View Trial DetailsCapsulectomy vs Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty
NCT02121964
Arthritis, Hip Arthrosis
Atlanta, Georgia, United States
View Trial Details